PF-03715455 potently inhibits LPS-induced TNFalpha production in human whole blood (IC50=1.7 nM). PF-03715455 is an effective inhibitor of inhaled p38 MAPK. PF-03715455 displays some selectivity for p38alpha over p38beta (respective IC50: 0.88 and 23 nM). PF-03715455 has the potential for the treatment of COPD.
Molekulargewicht:
700.27
CAS Nummer:
[1056164-52-3]
Formel:
C35H34ClN7O3S2
Target-Kategorie:
p38 MAPK
T16477
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten